Backed by a16z and QED, Brazilian startup Car...
Up next
Recommended Episodes
Artificial intelligence could help biopharmaceutical companies reduce costs as well as improve their chances of developing successful new drugs. ----- Transcript ----- Welcome to Thoughts on the Market. I'm Terence Flynn, Morgan Stanley's Head of U.S. Bi ...